(-)-demecolcine increases expression ISO RGD:1604845 6480464 Demecolcine results in increased expression of PLPP3 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1604845 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLPP3 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:731972 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PLPP3 mRNA CTD PMID:36331819 1,2-dichloroethane increases expression ISO RGD:731972 6480464 ethylene dichloride results in increased expression of PLPP3 mRNA, ethylene dichloride results in increased expression of PPAP2B mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:731972 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLPP3 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:731972 6480464 Ethinyl Estradiol affects the expression of PLPP3 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of PLPP3 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:1604845 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLPP3 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of PLPP3 mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PPAP2B mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO RGD:1604845 6480464 Estradiol results in increased expression of PLPP3 mRNA CTD PMID:23019147 17beta-estradiol decreases expression ISO RGD:1604845 6480464 Estradiol results in decreased expression of PLPP3 mRNA CTD PMID:16474171 , PMID:19619570 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1604845 6480464 Dihydrotestosterone results in increased expression of PLPP3 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1604845 6480464 2 more ... CTD PMID:23146750 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:731972 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1604845 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLPP3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLPP3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PLPP3 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731972 6480464 Tetrachlorodibenzodioxin affects the expression of PLPP3 mRNA CTD PMID:16962184 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1604845 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLPP3 mRNA CTD PMID:11007951 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731972 6480464 Tetrachlorodibenzodioxin results in increased expression of PLPP3 mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLPP3 mRNA CTD PMID:19490992 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731972 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of PLPP3 mRNA CTD PMID:16214954 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:731972 6480464 2 more ... CTD PMID:20702594 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of PLPP3 mRNA CTD PMID:17109745 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1604845 6480464 3 more ... CTD PMID:29947894 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1604845 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLPP3 mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:731972 6480464 Methylcholanthrene results in decreased expression of PLPP3 mRNA CTD PMID:20713471 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of PLPP3 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO RGD:731972 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PLPP3 mRNA CTD PMID:18648102 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:1604845 6480464 Am 580 results in increased expression of PLPP3 mRNA CTD PMID:16982809 6alpha-methylprednisolone decreases expression ISO RGD:1604845 6480464 Methylprednisolone results in decreased expression of PLPP3 mRNA CTD PMID:19192274 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PLPP3 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:731972 6480464 Aflatoxin B1 results in increased expression of PLPP3 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1604845 6480464 Aflatoxin B1 results in decreased methylation of PLPP3 gene CTD PMID:27153756 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of PLPP3 mRNA CTD PMID:17109745 all-trans-retinoic acid decreases expression ISO RGD:1604845 6480464 Tretinoin results in decreased expression of PLPP3 mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PLPP3 mRNA CTD PMID:16483693 arsane affects methylation ISO RGD:1604845 6480464 Arsenic affects the methylation of PLPP3 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1604845 6480464 Arsenic affects the methylation of PLPP3 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:1604845 6480464 Arsenic Trioxide results in increased expression of PLPP3 mRNA CTD PMID:19128835 ATP decreases chemical synthesis ISO RGD:731972 6480464 PLPP3 gene mutant form results in decreased chemical synthesis of Adenosine Triphosphate CTD PMID:28982073 azathioprine decreases expression ISO RGD:1604845 6480464 Azathioprine results in decreased expression of PLPP3 mRNA CTD PMID:19192274 benzene increases expression ISO RGD:1604845 6480464 Benzene results in increased expression of PLPP3 mRNA CTD PMID:19162166 benzo[a]pyrene increases expression ISO RGD:731972 6480464 Benzo(a)pyrene results in increased expression of PLPP3 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1604845 6480464 Benzo(a)pyrene affects the methylation of PLPP3 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1604845 6480464 Benzo(a)pyrene results in decreased expression of PLPP3 mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1604845 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of PLPP3 mRNA CTD PMID:17109745 bisphenol A decreases expression ISO RGD:1604845 6480464 bisphenol A results in decreased expression of PLPP3 mRNA CTD PMID:16474171 bisphenol A decreases methylation ISO RGD:1604845 6480464 bisphenol A results in decreased methylation of PLPP3 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1604845 6480464 bisphenol A results in increased expression of PLPP3 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLPP3 mRNA, bisphenol A results in decreased expression of PPAP2B mRNA CTD PMID:30816183 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PPAP2B mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PLPP3 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1604845 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PLPP3 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLPP3 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PLPP3 gene CTD PMID:28505145 Bisphenol B increases expression ISO RGD:1604845 6480464 bisphenol B results in increased expression of PLPP3 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1604845 6480464 bisphenol F results in increased expression of PLPP3 protein CTD PMID:34186270 buspirone increases expression EXP 6480464 Buspirone results in increased expression of PLPP3 mRNA CTD PMID:24136188 cadmium atom multiple interactions ISO RGD:1604845 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLPP3 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1604845 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLPP3 mRNA CTD PMID:35301059 cadmium sulfate multiple interactions ISO RGD:731972 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of PLPP3 mRNA] CTD PMID:16221973 calyculin a increases expression ISO RGD:731972 6480464 calyculin A results in increased expression of PLPP3 mRNA CTD PMID:25270620 cannabidiol increases expression ISO RGD:731972 6480464 Cannabidiol results in increased expression of PLPP3 mRNA CTD PMID:21542829 carbon nanotube decreases expression ISO RGD:731972 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of PLPP3 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:731972 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PLPP3 mRNA CTD PMID:20938992 cisplatin decreases expression ISO RGD:1604845 6480464 Cisplatin results in decreased expression of PLPP3 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1604845 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PLPP3 mRNA CTD PMID:27392435 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PLPP3 mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PLPP3 mRNA CTD PMID:24386269 cocaine increases expression EXP 6480464 Cocaine results in increased expression of PLPP3 mRNA CTD PMID:17898221 copper(II) sulfate decreases expression ISO RGD:1604845 6480464 Copper Sulfate results in decreased expression of PLPP3 mRNA CTD PMID:19549813 crocidolite asbestos affects expression ISO RGD:1604845 6480464 Asbestos, Crocidolite affects the expression of PLPP3 mRNA CTD PMID:24160326 crocidolite asbestos increases expression ISO RGD:1604845 6480464 Asbestos, Crocidolite results in increased expression of PLPP3 mRNA CTD PMID:18687144 , PMID:25757056 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PLPP3 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:1604845 6480464 Cyclosporine results in decreased expression of PLPP3 mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO RGD:1604845 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLPP3 mRNA CTD PMID:28628672 diallyl disulfide multiple interactions ISO RGD:1604845 6480464 diallyl disulfide inhibits the reaction [tobacco tar analog results in decreased expression of PPAP2B mRNA] CTD PMID:36758788 diarsenic trioxide increases expression ISO RGD:1604845 6480464 Arsenic Trioxide results in increased expression of PLPP3 mRNA CTD PMID:19128835 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PLPP3 mRNA CTD PMID:21266533 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of PLPP3 mRNA CTD PMID:23153324 dioxygen decreases metabolic processing ISO RGD:731972 6480464 PLPP3 gene mutant form results in decreased metabolism of Oxygen CTD PMID:28982073 dioxygen multiple interactions ISO RGD:731972 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPAP2B mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PLPP3 mRNA CTD PMID:25152437 divanadium pentaoxide affects expression ISO RGD:731972 6480464 vanadium pentoxide affects the expression of PLPP3 mRNA CTD PMID:26210822 doxorubicin decreases expression ISO RGD:1604845 6480464 Doxorubicin results in decreased expression of PLPP3 mRNA CTD PMID:29803840 elemental selenium decreases expression ISO RGD:1604845 6480464 Selenium results in decreased expression of PLPP3 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PLPP3 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1604845 6480464 entinostat results in increased expression of PLPP3 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:731972 6480464 epoxiconazole results in decreased expression of PLPP3 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:731972 6480464 Ethanol results in increased expression of PLPP3 mRNA, Ethanol results in increased expression of PPAP2B mRNA CTD PMID:19167417 , PMID:30319688 ethanol affects splicing ISO RGD:731972 6480464 Ethanol affects the splicing of PLPP3 mRNA CTD PMID:30319688 finasteride increases expression EXP 6480464 Finasteride results in increased expression of PLPP3 mRNA CTD PMID:24136188 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of PLPP3 mRNA CTD PMID:23962444 fipronil increases expression EXP 6480464 fipronil results in increased expression of PLPP3 mRNA CTD PMID:31881178 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PLPP3 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:731972 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:731972 6480464 Folic Acid results in decreased expression of PPAP2B mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1604845 6480464 Formaldehyde results in increased expression of PLPP3 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1604845 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PLPP3 gene CTD PMID:31601247 furan decreases expression EXP 6480464 furan results in decreased expression of PLPP3 mRNA CTD PMID:25539665 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of PLPP3 mRNA CTD PMID:17785943 genistein decreases expression ISO RGD:1604845 6480464 Genistein results in decreased expression of PLPP3 mRNA CTD PMID:16474171 genistein increases expression ISO RGD:1604845 6480464 Genistein results in increased expression of PLPP3 mRNA CTD PMID:23019147 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PLPP3 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of PLPP3 mRNA CTD PMID:24136188 graphite affects expression EXP 6480464 Graphite affects the expression of PLPP3 mRNA CTD PMID:29933104 hydrogen chloride decreases expression ISO RGD:1604845 6480464 Hydrochloric Acid results in decreased expression of PLPP3 mRNA CTD PMID:15046208 hydrogen peroxide affects expression ISO RGD:1604845 6480464 Hydrogen Peroxide affects the expression of PLPP3 mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:1604845 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLPP3 mRNA CTD PMID:28628672 isoflavones affects expression ISO RGD:1604845 6480464 Isoflavones affects the expression of PLPP3 mRNA CTD PMID:16365062 isotretinoin increases expression ISO RGD:1604845 6480464 Isotretinoin results in increased expression of PLPP3 mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:731972 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PLPP3 mRNA CTD PMID:20938992 lead diacetate increases expression ISO RGD:731972 6480464 lead acetate results in increased expression of PLPP3 mRNA CTD PMID:20542052 metacetamol decreases expression ISO RGD:731972 6480464 3-hydroxyacetanilide results in decreased expression of PLPP3 mRNA CTD PMID:18544908 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PPAP2B mRNA CTD PMID:30467583 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of PPAP2B mRNA CTD PMID:30047161 methotrexate increases expression ISO RGD:1604845 6480464 Methotrexate results in increased expression of PLPP3 mRNA CTD PMID:17400583 methotrexate decreases expression ISO RGD:1604845 6480464 Methotrexate results in decreased expression of PLPP3 mRNA CTD PMID:19192274 methylmercury chloride decreases expression ISO RGD:1604845 6480464 methylmercuric chloride results in decreased expression of PLPP3 mRNA CTD PMID:28001369 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of PLPP3 mRNA CTD PMID:20360939 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PLPP3 mRNA CTD PMID:17602206 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PLPP3 mRNA CTD PMID:24136188 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of PLPP3 mRNA CTD PMID:22110744 nickel dichloride increases expression ISO RGD:1604845 6480464 nickel chloride results in increased expression of PLPP3 mRNA CTD PMID:17312168 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PLPP3 mRNA CTD PMID:24136188 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PLPP3 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PLPP3 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:731972 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLPP3 mRNA CTD PMID:34911549 paracetamol decreases expression ISO RGD:731972 6480464 Acetaminophen results in decreased expression of PLPP3 mRNA CTD PMID:18544908 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PLPP3 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1604845 6480464 Acetaminophen results in decreased expression of PLPP3 mRNA, Acetaminophen results in decreased expression of PPAP2B mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression ISO RGD:731972 6480464 Acetaminophen affects the expression of PLPP3 mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:731972 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PLPP3 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PLPP3 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PLPP3 mRNA CTD PMID:19162173 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PLPP3 mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO RGD:731972 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLPP3 mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:1604845 6480464 Piroxicam results in decreased expression of PLPP3 mRNA CTD PMID:19192274 potassium chromate multiple interactions ISO RGD:1604845 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLPP3 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1604845 6480464 potassium chromate(VI) results in decreased expression of PLPP3 mRNA CTD PMID:22079256 prednisolone decreases expression ISO RGD:1604845 6480464 Prednisolone results in decreased expression of PLPP3 mRNA CTD PMID:19192274 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of PLPP3 mRNA CTD PMID:19162173 progesterone increases expression ISO RGD:1604845 6480464 Progesterone results in increased expression of PLPP3 mRNA CTD PMID:20864642 propiconazole decreases expression ISO RGD:731972 6480464 propiconazole results in decreased expression of PLPP3 mRNA CTD PMID:21278054 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of PLPP3 mRNA CTD PMID:19423681 raloxifene affects expression ISO RGD:1604845 6480464 Raloxifene Hydrochloride affects the expression of PLPP3 mRNA CTD PMID:14699072 raloxifene multiple interactions ISO RGD:1604845 6480464 ESR1 protein affects the reaction [Raloxifene Hydrochloride results in increased expression of PLPP3 mRNA] CTD PMID:14699072 Securinine decreases expression ISO RGD:1604845 6480464 securinine results in decreased expression of PLPP3 mRNA CTD PMID:32662633 selenium atom decreases expression ISO RGD:1604845 6480464 Selenium results in decreased expression of PLPP3 mRNA CTD PMID:19244175 serpentine asbestos affects expression ISO RGD:1604845 6480464 Asbestos, Serpentine affects the expression of PLPP3 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO RGD:1604845 6480464 Silicon Dioxide results in increased expression of PLPP3 mRNA CTD PMID:25351596 silicon dioxide increases expression ISO RGD:731972 6480464 Silicon Dioxide results in increased expression of PLPP3 mRNA CTD PMID:29203145 sodium arsenite increases expression ISO RGD:1604845 6480464 sodium arsenite results in increased expression of PLPP3 mRNA CTD PMID:28595984 , PMID:34032870 sodium arsenite increases expression ISO RGD:731972 6480464 sodium arsenite results in increased expression of PLPP3 protein CTD PMID:29044176 sodium aurothiomalate decreases expression ISO RGD:1604845 6480464 Gold Sodium Thiomalate results in decreased expression of PLPP3 mRNA CTD PMID:19192274 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of PLPP3 mRNA CTD PMID:22110744 sodium dodecyl sulfate increases expression ISO RGD:1604845 6480464 Sodium Dodecyl Sulfate results in increased expression of PLPP3 mRNA CTD PMID:31734321 sodium fluoride decreases expression ISO RGD:731972 6480464 Sodium Fluoride results in decreased expression of PLPP3 protein CTD PMID:28918527 succimer multiple interactions ISO RGD:731972 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLPP3 mRNA CTD PMID:21641980 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of PPAP2B mRNA CTD PMID:30047161 tamoxifen affects expression ISO RGD:731972 6480464 Tamoxifen affects the expression of PLPP3 mRNA CTD PMID:17555576 testosterone enanthate affects expression ISO RGD:1604845 6480464 testosterone enanthate affects the expression of PLPP3 mRNA CTD PMID:17440010 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PLPP3 mRNA CTD PMID:16239168 , PMID:31150632 tetrachloromethane decreases expression ISO RGD:731972 6480464 Carbon Tetrachloride results in decreased expression of PLPP3 mRNA CTD PMID:27339419 , PMID:31919559 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PLPP3 mRNA CTD PMID:23411599 , PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PLPP3 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of PLPP3 mRNA CTD PMID:25729387 triadimefon decreases expression EXP 6480464 triadimefon results in decreased expression of PPAP2B mRNA CTD PMID:30047161 triclosan increases expression ISO RGD:1604845 6480464 Triclosan results in increased expression of PPAP2B mRNA CTD PMID:30510588 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of PLPP3 mRNA CTD PMID:30589522 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PLPP3 protein CTD PMID:32519852 troglitazone decreases expression ISO RGD:731972 6480464 troglitazone results in decreased expression of PLPP3 mRNA CTD PMID:28973697 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of PLPP3 mRNA CTD PMID:24136188 tunicamycin decreases expression ISO RGD:1604845 6480464 Tunicamycin results in decreased expression of PLPP3 mRNA CTD PMID:22378314 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of PLPP3 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1604845 6480464 Valproic Acid affects the expression of PLPP3 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1604845 6480464 Valproic Acid results in decreased expression of PLPP3 mRNA, Valproic Acid results in decreased expression of PPAP2B mRNA CTD PMID:24935251 more ... valproic acid increases expression ISO RGD:1604845 6480464 Valproic Acid results in increased expression of PLPP3 mRNA CTD PMID:24935251 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of PLPP3 promoter CTD PMID:22570695 vincristine increases expression ISO RGD:1604845 6480464 Vincristine results in increased expression of PLPP3 mRNA CTD PMID:23649840 vitamin E increases expression ISO RGD:1604845 6480464 Vitamin E results in increased expression of PLPP3 mRNA CTD PMID:19244175 zinc atom multiple interactions ISO RGD:1604845 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PLPP3 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1604845 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PLPP3 mRNA CTD PMID:18593933 zoledronic acid increases expression ISO RGD:1604845 6480464 zoledronic acid results in increased expression of PLPP3 mRNA CTD PMID:24714768